SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
56.00    1.40 (2.56%)
Bid:
54.60
Ask:
56.00
Spread: 1.40 (2.564%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Statement re Unsolicited Offe

2 Jun 2008 07:00

RNS Number : 7095V
Flomerics Group PLC
02 June 2008
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATESAUSTRALIACANADA OR JAPAN

FOR IMMEDIATE RELEASE 2 June 2008

FLOMERICS GROUP PLC

Statement re: Unsolicited Offer

The Board of Directors of Flomerics Group PLC ('Flomerics' or the 'Company') notes the statement by Mentor Graphics, Inc. ('Mentor') that it has posted a letter, dated 30 May 2008, to Flomerics shareholders.

The Board of Directors of Flomerics have reviewed the Mentor letter, and in light of the fact that they believe it is misleading, intend to issue a response as soon as possible.

The Board of Directors of Flomerics continue to believe the Offer undervalues the Company and are actively assessing other alternatives available to the Company, including potential interest expressed by a number of other parties.

Any discussions with other interested parties are at an early stage and there can be no certainty that an alternative offer will be forthcoming. However, shareholders are strongly recommended to take no action at this stage.

Enquiries:

Flomerics Group PLC  Tel: 020 8487 3000

Gary Carter

Keith Butcher

Jefferies International Ltd Tel: 020 7029 8000

Andres Pieczanski

Sarah McNicholas

Oriel Securities Ltd Tel: 020 7710 7600

Andrew Edwards

Michael Shaw

Citigate Dewe Rogerson Tel: 020 7638 9571

Ginny Pulbrook

Seb Hoyle

  Pursuant to Rule 2.10 of the City Code, Flomerics confirms that it has 22,935,250 ordinary shares of one penny each in issue and admitted to trading on the Alternative Investment Market of the London Stock Exchange (ISIN GB0003436192).

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the 'Code'), if any person is, or becomes, 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of Flomerics, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Nestor, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Flomerics by a potential offeror or by Flomerics, or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel. 

Note to Editors

Flomerics (www.flomerics.com) is a world-leading developer of engineering simulation software and services for analysis of fluid flow, heat transfer. Flomerics' business model is drastically different from traditional analysis because its software is designed to be embedded deeply into the design process and used by mainstream design engineers, not just by analysis specialists. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREASKAESFPEEE
Date   Source Headline
31st Jan 20197:00 amRNSTrading Update & Notice of Full Year Results
29th Jan 20197:00 amRNSHolding(s) in Company
23rd Jan 20199:42 amRNSChange of Registered Office
27th Nov 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSDeferred Consideration and Total Voting Rights
23rd Oct 20187:00 amRNSTrading update - nine month period ended 30.9.18
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20187:00 amRNSHolding(s) in Company
1st Oct 20183:03 pmRNS2018 Half-year Report Published
27th Sep 201812:06 pmRNSDirector/PDMR Shareholding
24th Sep 201810:02 amRNSDirector/PDMR Shareholding
20th Sep 20186:04 pmRNSDirector/PDMR Shareholding
20th Sep 20181:20 pmRNSDirector/PDMR Shareholding
18th Sep 20187:01 amRNSHalf-year Report
18th Sep 20187:00 amRNSDirectorate Changes
24th Aug 20181:57 pmRNSHolding(s) in Company- updated
23rd Aug 20183:53 pmRNSHolding(s) in Company
24th Jul 20186:24 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSGroup Trading Update & Notice of HY Results
6th Jun 201811:10 amRNSResult of AGM
6th Jun 20187:00 amRNSAGM Statement
21st May 20183:46 pmRNSHolding(s) in Company
14th May 20187:00 amRNSOption Exercise and Director's Dealings
4th May 20183:30 pmRNS2017 Annual Report - year ended 31 December 2017
27th Apr 20185:51 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSHolding(s) in Company
17th Apr 20187:01 amRNSQ1 2018 Quarter Results
17th Apr 20187:00 amRNSFinal statement of results - year ended 31.12.17
9th Apr 201811:35 amRNSHolding(s) in Company
3rd Apr 201811:24 amRNSResult of General Meeting & Total Voting Rights
26th Mar 201812:18 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSFlowtech Chairman receives FTSE AIM NED award
20th Mar 20183:16 pmRNSCompletion of the acquisition of Balu Limited
19th Mar 20182:39 pmRNSHolding(s) in Company
19th Mar 201811:52 amRNSOption Exercise and Director's Dealings
15th Mar 20187:00 amRNSPosting of circular
14th Mar 20187:00 amRNSAcquisition of Balu Ltd - Placing to raise £11m
1st Mar 201812:03 pmRNSHolding(s) in Company
26th Feb 201812:51 pmRNSHolding(s) in Company
23rd Jan 20187:00 amRNS2017 Trading Update & Notice of Full-Year Results
19th Oct 20171:54 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSQ3 Group Trading Update
12th Oct 20177:00 amRNSAcquisition of Group HES, New Division established
27th Sep 20173:57 pmRNSSilver award winner for 2017 online Annual Report
22nd Sep 20172:48 pmRNSHolding(s) in Company
19th Sep 20176:36 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSOrganic & acquisition strategy underpins future
7th Sep 20173:38 pmRNSFLOWTECH EXPANDS ITS FOOTPRINT IN EUROPE
10th Jul 20177:00 amRNSGroup Trading update & Notice of HY results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.